Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Type NHS provider Performance in Initiating Leicestershire Partnership NHS Trust Id Research Ethics Committee Reference Number Name of Trial Date of Receipt of VRA Date of NHS Permission First Patient Recruited? Date of First Patient Recruite d Duration between VRA and NHS Permissi on 70879 14/LO/0055 Improving outcomes in adults with epilepsy and intellectual disability: A cluster randomised controlled trial of nurse-led epilepsy management (EpAID) 15/06/2015 29/06/201 5 Yes 22/07/20 15 70880 14/NW/0297 11/02/2015 20/02/201 5 Yes 70881 14/NI/0069 21/12/2014 05/01/201 5 70882 14/SC/1340 17/09/2015 70883 09/H1005/28 EQUIP: Enhancing the quality of user involved care planning in mental health services (EQUIP): Clinical randomised control trial and process evaluation A randomised controlled trial of calcium channel blockade with amlodipine for the treatment of subcortical ischaemic vascular dementia LEGATO-HD (Laquinimod Efficacy and Safety in a GlobAl Trial Of HD) Molecular Genetics of Adverse Drug Reactions 10/09/2015 Showing records 1 to 5 of 5. Pages: 1 Duration between VRA and First Patient Benchmark Met 14 Duration between NHS Permissi on and First Patient 23 A - Permissions delayed/denied BSuspended by sponsor CClosed by sponsor DSponsor Delays E - Staff availability issues F - No patients seen 37 Yes 10/03/20 15 9 18 27 Yes Yes 12/06/20 15 15 158 173 No Y 28/09/201 5 Yes 20/12/20 15 11 83 94 No Y 01/10/201 5 Yes 24/11/20 15 21 54 75 No Y Y G - No patients consented HContracting delays I - Rare diseases Y JOther Comments Reasons for delay correspond to: Key service contact providing information on target population absent on sick leave will lead to recruitment delays. N/A N/A Y First Patient now in Study Y Both NHS Provider Extensive Screening undertaken but 95% patient not eligible for inlcusion. Neither